A Phase I/IIa safety and efficacy study of nebulized liposome-mediated gene therapy for cystic fibrosis supports a multidose trial
File(s)
Author(s)
Type
Journal Article
Date Issued
2015-12-01
Date Acceptance
2015-08-02
Citation
American Journal of Respiratory and Critical Care Medicine, 2015, 192 (11), pp.1389-1392
ISSN
1535-4970
Publisher
American Thoracic Society
Start Page
1389
End Page
1392
Journal / Book Title
American Journal of Respiratory and Critical Care Medicine
Volume
192
Issue
11
Copyright Statement
© 2015 by the American Thoracic Society
Publication Status
Published